Skip to main content
. 2020 Nov 10;17(5):491–501. doi: 10.2217/fon-2020-0737

Figure 1. . KEYNOTE-811 study design.

Figure 1. 

(A) Global cohort. (B) Japan-specific S-1 + oxaliplatin cohort.

CAPOX: Capecitabine + oxaliplatin; FP: 5-Fluorouracil + cisplatin; R: Randomization; SOX: S-1 + oxaliplatin.